ABOUT U-73122

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely formulated TPD procedures. With this critique, we deal with both of those preclinical experiments and clinical trials to provide an extensive summary of the protection and scientific efficiency of PROTACs and MGDs in hematologic malignanci